NCT05970237View on ClinicalTrials.gov

A Study to Evaluate the Efficacy and Safety of Dapagliflozin in Patient With Type 2 Diabetes Mellitus and Hypertension

RecruitingOBSERVATIONAL
Enrollment

9,000

Participants

Timeline

Start Date

July 26, 2023

Primary Completion Date

October 21, 2025

Study Completion Date

October 21, 2025

Conditions
Diabetes MellitusHypertension
Trial Locations (1)

21565

RECRUITING

Gachon University Gil Medical Center, Incheon

Sponsors
All Listed Sponsors
lead

Boryung Pharmaceutical Co., Ltd

INDUSTRY